DecisionDx®-SCC is a genomic prognostic test that better identifies risk of metastases based on the biologic profile of genes within tumor tissue in SCC patients with one or more high-risk factors.

Returning Customer Orders

In advance of the cutaneous melanoma specimen collection, download the requisition form located below.

After the form is completed, sign and fax it with a copy of the patient’s insurance information to 866-329-2224.

Castle will then initiate a benefits investigation and coordinate specimen collection with the physician’s staff and hospital.

Patient results will be sent to the physician(s) indicated on the requisition form.

Scroll to Top
Scroll to Top